tirzepatide 60mg/3ml 60mg disposable pen and 3ml Cartridge for Weight Loss 60 mg 3 ml tirzepatide

Jakie skutki uboczne maj GLP-1

Obesity can cause a host of health problems, including various cancers, coronary heart disease, high blood pressure, stroke, Type 2 diabetes, sleep apnea and more

Tirzepatide, a dual glucagon-like peptide-1 (GIP) and GLP-1RAs, administered once weekly at a 15 mg dose, resulted in an average weight loss of 20.9% over 72 weeks (Jastreboff et al., 2022), driven by its synergistic effects on appetite regulation, energy intake reduction, and fat mass decrease (Heise et al., 2023)

So maybe the drug needs to be used in combination with a sensible diet and exercise regime, if the weight is to stay off